OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

OROPHARYNGEAL SQUAMOUS CELL CARCINOMA was reported 144 times

OROPHARYNGEAL SQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sulfonamide Antibacterial [EPC] 1 0.0003
1 SLAMF7-directed Immunostimulatory Antibody [EPC] 1 0.0002
2 Antimalarial [EPC] 2 0.0002
3 Antiprotozoal [EPC] 2 0.0002
4 Antimetabolite Immunosuppressant [EPC] 4 0.0002
5 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
6 Phenothiazine [EPC] 4 0.0001
7 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 2 0.0001
8 Purine Antimetabolite [EPC] 11 0.0001
9 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
10 Provitamin D2 Compound [EPC] 3 0.0001
11 Vitamin D3 Analog [EPC] 2 0.0001
12 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 2 0.0001
13 Protease Inhibitor [EPC] 4 0.0001
14 Epidermal Growth Factor Receptor Antagonist [EPC] 4 0.0001
15 Programmed Death Receptor-1 Blocking Antibody [EPC] 7 0.0001
16 Alkylating Drug [EPC] 17 0.0001
17 Cytochrome P450 3A Inhibitor [EPC] 4 0.0001
18 Topoisomerase Inhibitor [EPC] 5 0.0001
19 Platinum-based Drug [EPC] 17 0.0001
20 Sympathomimetic-like Agent [EPC] 2 0.0001
21 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1 0.0001
22 Interleukin-23 Antagonist [EPC] 6 0.0001
23 Human Immunoglobulin G [EPC] 1 0.0000
24 CD20-directed Cytolytic Antibody [EPC] 15 0.0000
25 Pyrimidine Synthesis Inhibitor [EPC] 2 0.0000
26 Nucleoside Metabolic Inhibitor [EPC] 12 0.0000
27 Macrolide Antimicrobial [EPC] 2 0.0000
28 Complement Inhibitor [EPC] 2 0.0000
29 Proteasome Inhibitor [EPC] 4 0.0000
30 Integrin Receptor Antagonist [EPC] 3 0.0000
31 Janus Kinase Inhibitor [EPC] 5 0.0000
32 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
33 Serotonin-3 Receptor Antagonist [EPC] 4 0.0000
34 Tetracycline-class Drug [EPC] 2 0.0000
35 Corticosteroid [EPC] 36 0.0000
36 Interleukin-17A Antagonist [EPC] 1 0.0000
37 Microtubule Inhibitor [EPC] 4 0.0000
38 Folate Analog Metabolic Inhibitor [EPC] 10 0.0000
39 Serotonin Reuptake Inhibitor [EPC] 2 0.0000
40 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
41 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
42 Aminosalicylate [EPC] 2 0.0000
43 Vitamin D [EPC] 6 0.0000
44 Interleukin-12 Antagonist [EPC] 2 0.0000
45 Vitamin B12 [EPC] 6 0.0000
46 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
47 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
48 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
49 Interferon beta [EPC] 3 0.0000
50 Thalidomide Analog [EPC] 8 0.0000
51 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
52 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
53 Vitamin C [EPC] 6 0.0000
54 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
55 alpha-Adrenergic Blocker [EPC] 2 0.0000
56 Androgen Receptor Inhibitor [EPC] 1 0.0000
57 Benzodiazepine [EPC] 9 0.0000
58 Catecholamine [EPC] 1 0.0000
59 Proton Pump Inhibitor [EPC] 7 0.0000
60 Nucleoside Analog Antiviral [EPC] 1 0.0000
61 Nitrate Vasodilator [EPC] 1 0.0000
62 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
63 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
64 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
65 Antirheumatic Agent [EPC] 1 0.0000
66 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
67 Mood Stabilizer [EPC] 2 0.0000
68 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
69 Tumor Necrosis Factor Blocker [EPC] 9 0.0000
70 Kinase Inhibitor [EPC] 5 0.0000
71 Aromatase Inhibitor [EPC] 1 0.0000
72 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
73 Factor Xa Inhibitor [EPC] 2 0.0000
74 Calcium [EPC] 1 0.0000
75 beta-Adrenergic Blocker [EPC] 2 0.0000
76 Azole Antifungal [EPC] 1 0.0000
77 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
78 Platelet Aggregation Inhibitor [EPC] 3 0.0000
79 Expectorant [EPC] 1 0.0000
80 Anti-epileptic Agent [EPC] 1 0.0000
81 Loop Diuretic [EPC] 2 0.0000
82 Opioid Agonist [EPC] 1 0.0000
83 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000